Luciano Mutti Selected Research

LCRF-0004

1/2019

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luciano Mutti Research Topics

Disease

68	Neoplasms (Cancer) 03/2024 - 10/2002
66	Malignant Mesothelioma 01/2023 - 02/2002
36	Mesothelioma 04/2024 - 02/2002
9	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2007
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2023 - 01/2020
5	Carcinogenesis 12/2020 - 03/2010
4	Rare Diseases (Rare Disease) 02/2020 - 06/2005
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2015
3	Genetic Predisposition to Disease (Genetic Predisposition) 07/2008 - 10/2002
2	Inflammation (Inflammations) 03/2024 - 11/2017
2	Brain Neoplasms (Brain Tumor) 03/2023 - 01/2022
2	Adenocarcinoma of Lung 01/2022 - 01/2022
2	Disease Progression 12/2020 - 06/2009
2	Breast Neoplasms (Breast Cancer) 12/2020 - 06/2016
2	Neoplasm Metastasis (Metastasis) 11/2015 - 09/2009
2	Pleural Effusion (Pleural Effusions) 03/2010 - 11/2002
1	Cicatrix (Scar) 03/2024
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2023
1	Multiple Myeloma 01/2023
1	Triple Negative Breast Neoplasms 12/2020
1	COVID-19 07/2020
1	Autoimmune Diseases (Autoimmune Disease) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Disease Resistance 11/2017

Drug/Important Bio-Agent (IBA)

23	AsbestosIBA 03/2024 - 10/2002
12	MMEIBA 01/2023 - 11/2002
7	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2020
7	MesothelinIBA 01/2017 - 09/2007
5	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2012
4	Pemetrexed (MTA)FDA Link 01/2022 - 08/2007
4	Proteins (Proteins, Gene)FDA Link 12/2021 - 09/2007
4	MicroRNAs (MicroRNA)IBA 01/2020 - 03/2010
4	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 01/2007
4	Tumor Viral Antigens (Large T Antigen)IBA 07/2005 - 01/2003
3	Bortezomib (Velcade)FDA Link 01/2023 - 10/2007
3	Indicators and Reagents (Reagents)IBA 01/2023 - 01/2012
3	Long Noncoding RNAIBA 01/2022 - 01/2022
3	Estrogen ReceptorsIBA 12/2020 - 06/2009
3	Gemcitabine FDA Link 01/2019 - 08/2007
3	Peptides (Polypeptides)IBA 01/2017 - 07/2010
3	tremelimumabIBA 01/2017 - 10/2013
3	Phosphotransferases (Kinase)IBA 11/2015 - 05/2005
3	Estrogen Receptor betaIBA 01/2012 - 06/2009
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 01/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2002
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
2	Bevacizumab (Avastin)FDA Link 01/2022 - 08/2017
2	Sirtuin 1IBA 12/2021 - 02/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021 - 02/2002
2	Messenger RNA (mRNA)IBA 12/2020 - 02/2010
2	EnzymesIBA 12/2020 - 12/2009
2	HLA-B Antigens (HLA-B)IBA 07/2020 - 01/2020
2	Monoclonal AntibodiesIBA 01/2020 - 10/2013
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2016
2	Epidermal Growth Factor (EGF)IBA 01/2017 - 03/2010
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 01/2008
2	Small Interfering RNA (siRNA)IBA 11/2015 - 11/2012
2	PolyphenolsIBA 12/2013 - 11/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 12/2013 - 11/2012
2	Gefitinib (Iressa)FDA Link 11/2010 - 03/2010
2	ranpirnase (Pannon)IBA 12/2008 - 05/2005
1	Chymotrypsin FDA Link 01/2023
1	alexidineIBA 05/2022
1	CaspasesIBA 05/2022
1	atezolizumabIBA 01/2022
1	durvalumabIBA 01/2022
1	pembrolizumabIBA 01/2022
1	avelumabIBA 01/2022
1	abemaciclibIBA 01/2022
1	Circular RNAIBA 01/2022
1	NivolumabIBA 01/2022
1	Serine (L-Serine)FDA Link 12/2021
1	Lysine (L-Lysine)FDA Link 12/2021
1	Cyclin D1IBA 08/2021
1	Circulating Tumor DNAIBA 05/2021
1	Tumor Biomarkers (Tumor Markers)IBA 05/2021
1	ProcalcitoninIBA 01/2021
1	Protein Disulfide-IsomerasesIBA 12/2020
1	Adenosine Triphosphate (ATP)IBA 12/2020
1	HLA-C Antigens (HLA-C)IBA 07/2020
1	51 CIBA 07/2020
1	HLA-A Antigens (HLA-A)IBA 07/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	5'-methylthioadenosineIBA 01/2020
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2020
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 01/2020
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	N- (4- (2- amino- 3- chloropyridin- 4- yloxy)- 3- fluorophenyl)- 4- ethoxy- 1- (4- fluorophenyl)- 2- oxo- 1,2- dihydropyridine- 3- carboxamideIBA 01/2019
1	LCRF-0004IBA 01/2019
1	SirtuinsIBA 01/2019
1	Hormones (Hormone)IBA 11/2017

Therapy/Procedure

30	Therapeutics 05/2022 - 06/2005
12	Immunotherapy 04/2024 - 10/2011
12	Drug Therapy (Chemotherapy) 01/2023 - 03/2008
7	Radiotherapy 03/2023 - 01/2017
1	Palliative Care (Palliative Therapy) 01/2023
1	Intravenous Administration 01/2023
1	Salvage Therapy 02/2020